1 | 19885-10-0 | 泽泻醇A | Alisol A | C30H50O5
| 标准品;对照品;中药对照品;植物提取物;分析试剂标准品;标准品-对照品;标准品-中药标准品;标准品 -中药标准品 | |
2 | 246868-97-3 | Aglinin A | Aglinin A | C30H50O5
| 三萜;植物提取物 | |
3 | 211506-71-7 | viburgenin | viburgenin | C30H50O5
| | |
4 | 25278-95-9 | MELIANTRIOL | MELIANTRIOL | C30H50O5
| | |
5 | 104121-92-8 | Eldecalcitol | Eldecalcitol | C30H50O5
| 原料药;医药原料;化工原料;日用原料;化学试剂;黄金产品 | |
6 | 925932-10-1 | SECAUBRYTRIOL | Secaubrytriol | C30H50O5
| 三萜;标准品 | |
7 | 84605-18-5 | 环黄芪醇 | Cycloastragenol | C30H50O5
| 对照品;标准品;医药原料;植提标准品;中药对照品;植物提取物;对照品,标准品 | |
8 | 158689-03-3 | 2Α-(3-羟丙基)氧基-1Α,25-二羟基维生素D3 | 1β-eldecalcitol | C30H50O5
| | |
9 | 861996-34-1 | 2β-trans-eldecalcitol | 2β-trans-eldecalcitol | C30H50O5
| 杂质对照品;对照品-杂质对照品 | 对照品-杂质对照品;杂质对照品 |
10 | 201854-22-0 | Eldecalcitol Impurity 3 | Eldecalcitol Impurity 3 | C30H50O5
| | |
11 | 19942-02-0 | (3BETA,4ALPHA,16BETA,21BETA)-齐墩果-12-烯-3,16,21,23,28-五醇 | Olean-12-ene-3β,16β,21β,23,28-pentol | C30H50O5
| 标准品;对照品;标准品,对照品 | |
12 | | 1ALPHA,25-DIHYDROXYVITAMIND3PROPYLENEGLYCOL | 1ALPHA,25-DIHYDROXYVITAMIND3PROPYLENEGLYCOL | C30H50O5
| | |
13 | 96820-46-1 | (+)-Oleana-12-ene-3β,21β,22β,24,29-pentol | (+)-Oleana-12-ene-3β,21β,22β,24,29-pentol | C30H50O5
| | |
14 | | [R,(-)]-3-O-Benzyl-1-O,2-O-didecanoyl-D-glycerol | [R,(-)]-3-O-Benzyl-1-O,2-O-didecanoyl-D-glycerol | C30H50O5
| | |
15 | 114612-72-5 | Lanost-8-en-7-one, 3,24,25,26-tetrahydroxy-, (3β)- | Lanost-8-en-7-one, 3,24,25,26-tetrahydroxy-, (3β)- | C30H50O5
| | |
16 | 97190-36-8 | (24ξ)-Ergost-5-ene-1α,3β,11α,18-tetrol 18-acetate | (24ξ)-Ergost-5-ene-1α,3β,11α,18-tetrol 18-acetate | C30H50O5
| | |
17 | 97190-38-0 | 5α-Ergost-24(28)-ene-1α,3β,11α,18-tetrol 18-acetate | 5α-Ergost-24(28)-ene-1α,3β,11α,18-tetrol 18-acetate | C30H50O5
| | |
18 | 144337-28-0 | 1,1''-(2,4,6-Trihydroxy-1,3-phenylene)bis(dodecan-1-one) | 1,1''-(2,4,6-Trihydroxy-1,3-phenylene)bis(dodecan-1-one) | C30H50O5
| | |
19 | 36872-80-7 | (20ξ)-3β,20,23-Trihydroxy-5α-lanost-9(11)-en-18-oic acid | (20ξ)-3β,20,23-Trihydroxy-5α-lanost-9(11)-en-18-oic acid | C30H50O5
| | |
20 | 11026-01-0 | (24R)-20,24-Epoxy-5α-lanost-9(11)-ene-3β,6α,16β,25-tetrol | (24R)-20,24-Epoxy-5α-lanost-9(11)-ene-3β,6α,16β,25-tetrol | C30H50O5
| | |
21 | 1361033-59-1 | 9,19-Cyclolanostan-30-oic acid, 3,24,25-trihydroxy-, (3β,24R)- | 9,19-Cyclolanostan-30-oic acid, 3,24,25-trihydroxy-, (3β,24R)- | C30H50O5
| | |
22 | 85045-03-0 | (20E,24S)-3β,19-Epoxy-5α-dammar-20(22)-ene-3α,11α,24,25-tetrol | (20E,24S)-3β,19-Epoxy-5α-dammar-20(22)-ene-3α,11α,24,25-tetrol | C30H50O5
| | |
23 | 11076-26-9 | (24R)-3α,24,25-Trihydroxy-B(9a)-homo-19-norlanost-5(10)-en-30-oic acid | (24R)-3α,24,25-Trihydroxy-B(9a)-homo-19-norlanost-5(10)-en-30-oic acid | C30H50O5
| | |
24 | 142719-37-7 | 9,19-Cyclolanostane-3,7,16,25-tetrol,20,24-epoxy-, (3b,7b,16b,20R,24S)- (9CI) | 9,19-Cyclolanostane-3,7,16,25-tetrol,20,24-epoxy-, (3b,7b,16b,20R,24S)- (9CI) | C30H50O5
| | |
25 | 33573-46-5 | (13α,17α,20S,23R,24R)-21,24-Epoxy-4,4,8-trimethyl-5α-cholest-14-ene-3α,7α,23,25-tetrol | (13α,17α,20S,23R,24R)-21,24-Epoxy-4,4,8-trimethyl-5α-cholest-14-ene-3α,7α,23,25-tetrol | C30H50O5
| | |
26 | 86748-30-3 | (3R,9aα)-Decahydro-2,2,5aβ,7α-tetramethyl-6β-[2-[(3R,3aR,8aR)-1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-3,6,8,8-tetramethyl-5-oxoazulen-7-yl]ethyl]-1-benzoxepine-3α,7β-diol | (3R,9aα)-Decahydro-2,2,5aβ,7α-tetramethyl-6β-[2-[(3R,3aR,8aR)-1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-3,6,8,8-tetramethyl-5-oxoazulen-7-yl]ethyl]-1-benzoxepine-3α,7β-diol | C30H50O5
| | |
27 | 1217549-27-3 | 1,3-Cyclohexanediol, 2-(3-hydroxypropoxy)-4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1S)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,2R,3R,5Z)- | 1,3-Cyclohexanediol, 2-(3-hydroxypropoxy)-4-methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1S)-5-hydroxy-1,5-dimethylhexyl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,2R,3R,5Z)- | C30H50O5
| | |